Literature DB >> 14609173

Metastatic melanoma of the pituitary gland. Case report.

Gilberto Ka Kit Leung1, Wing Sun Chow, Kathryn Choon Beng Tan, Yiu Wah Fan, Karen Siu Ling Lam.   

Abstract

The authors report on the clinical features and imaging studies in a case of metastatic melanoma of the pituitary gland. Cerebral metastatic melanoma and pituitary metastasis from any source are commonly associated with systemic metastasis, whereas pituitary metastatic melanoma without widespread disease dissemination is distinctly rare. This 46-year-old man presented with diabetes insipidus and anterior pituitary dysfunction 5 years after he underwent resection of a cutaneous malignant melanoma of the neck. Magnetic resonance imaging demonstrated the presence of melanin within a sellar tumor mass. Transsphenoidal resection was performed and histopathological examination of tumor material confirmed metastatic melanoma. Postoperative [18F]fluorodeoxyglucose-positron emission tomography revealed no other focus of hypermetabolism in the patient's body.

Entities:  

Mesh:

Year:  2003        PMID: 14609173     DOI: 10.3171/jns.2003.99.5.0913

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

Review 1.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 2.  Twelve cases of pituitary metastasis: a case series and review of the literature.

Authors:  Mendel Castle-Kirszbaum; Tony Goldschlager; Benjamin Ho; Yi Yuen Wang; James King
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 3.  Primary sellar melanocytoma.

Authors:  M Claus; M Van Der Linden; J Van Dorpe; B Lapauw; G T'Sjoen
Journal:  Pituitary       Date:  2021-09-13       Impact factor: 4.107

Review 4.  Multiple intracranial melanoma metastases: case report and review of the literature.

Authors:  Aslan Guzel; Jaroslaw Maciaczyk; Hildegard Dohmen-Scheufler; Senem Senturk; Benedikt Volk; Christoph B Ostertag; Guido Nikkhah
Journal:  J Neurooncol       Date:  2009-02-01       Impact factor: 4.130

Review 5.  Primary sellar melanocytic tumor: report of new case and literature review.

Authors:  Delphine Vezzosi; Caroline Capuani; Florence Loubes-Lacroix; Jacques Lagarrigue; Antoine Bennet; Marie Bernadette Delisle; Philippe Caron
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 6.  Primary sellar melanocytoma: pathological, clinical and treatment review.

Authors:  L Albano; M Losa; L R Barzaghi; G Spatola; P Panni; M R Terreni; P Mortini
Journal:  J Endocrinol Invest       Date:  2019-12-03       Impact factor: 4.256

7.  Pituitary apoplexy caused by hemorrhage from pituitary metastatic melanoma: case report.

Authors:  Katsuya Masui; Taiji Yonezawa; Yukei Shinji; Ryo Nakano; Seisuke Miyamae
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

8.  Transformation of a Silent Adrencorticotrophic Pituitary Tumor Into Central Nervous System Melanoma.

Authors:  Brandon A Miller; Tomoko Tanaka; Adriana G Ioachimescu; Cristina Vincentelli; Christina L Appin; Nelson M Oyesiku
Journal:  J Investig Med High Impact Case Rep       Date:  2013-06-17

Review 9.  Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review.

Authors:  Chuanwei Yang; Ling Liu; Xiaoqiang Lan; Shiqiang Zhang; Xinyu Li; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  A Rare Case of Pituitary Melanoma Metastasis: A Dramatic and Prolonged Response to Dabrafenib-Trametinib Therapy.

Authors:  Marilda Mormando; Giulia Puliani; Agnese Barnabei; Rosa Lauretta; Marta Bianchini; Alfonsina Chiefari; Michelangelo Russillo; Francesco Cognetti; Luisa Romano; Marialuisa Appetecchia
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.